Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-020165

EVP, North America Commercial sold 470 shares at $7.16 ($3,367)

  • EVP, North America Commercial acquired 1,179 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

O'Grady Brendan P. · EVP, North America Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-17 Exercise or conversion : show line 1 in the form +1,179 15,338.49 D
2020-03-17 Sale : show line 2 in the form −470 $7.16 $3,367 14,868.49 D
Open-market sales · 470 sh · avg $7.16 · $3,367

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-03-17 Exercise or conversion : show line 3 in the form Restricted Share Units −1,179 0 D
Loading xslF345X03/doc4.xml…